表紙
市場調查報告書

膀胱癌治療的全球市場

Bladder Cancer Therapeutics

出版商 Global Industry Analysts, Inc. 商品編碼 912665
出版日期 內容資訊 英文 260 Pages
商品交期: 最快1-2個工作天內
價格
Back to Top
膀胱癌治療的全球市場 Bladder Cancer Therapeutics
出版日期: 2019年10月01日內容資訊: 英文 260 Pages
簡介

本報告提供全球膀胱癌治療市場調查,提供市場概要,各類型(轉移表皮膀胱癌,非肌肉侵襲性膀胱癌,表淺性膀胱癌,浸潤性膀胱癌,膀胱鱗狀細胞癌,膀胱腺癌,罕見膀胱癌),治療方法(外科手術,化療,免疫療法,放射治療,膀胱內療法),各地區的市場佔有率,需求趨勢,銷售額的變化與預測,市場成長要素,競爭情形,主要企業的簡介等全面性資訊。

第1章 調查手法

第2章 摘要整理

  • 市場概要
    • 競爭企業的市場佔有率
    • 競爭企業的市場佔有率:方案
  • 關注企業
  • 市場趨勢和成長要素
  • 全球市場預測

第3章 市場分析

  • 地區市場分析
  • 美國
    • 市場概要
    • 市場佔有率:各企業
  • 加拿大
  • 日本
  • 中國
  • 歐洲
  • 法國
  • 德國
  • 義大利
  • 英國
  • 西班牙
  • 俄羅斯
  • 其他歐洲各國
  • 亞太地區
  • 澳洲
  • 印度
  • 韓國
  • 其他的亞太地區
  • 南美
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他南美地區
  • 中東
  • 伊朗
  • 以色列
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 其他中東地區
  • 非洲

第4章 競爭情形

  • ASTRAZENECA PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • CELGENE CORPORATION
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • NOVARTIS INTERNATIONAL AG
  • PFIZER

第5章 調查資料

目錄
Product Code: MCP-6020

Bladder Cancer Therapeutics market worldwide is projected to grow by US$89.9 Million, driven by a compounded growth of 4.8%. Transitional Cell Bladder Cancer, one of the segments analyzed and sized in this study, displays the potential to grow at over 5.6%. The shifting dynamics supporting this growth makes it critical for businesses in this space to keep abreast of the changing pulse of the market. Poised to reach over US$111.4 Million by the year 2025, Transitional Cell Bladder Cancer will bring in healthy gains adding significant momentum to global growth.

Representing the developed world, the United States will maintain a 3.7% growth momentum. Within Europe, which continues to remain an important element in the world economy, Germany will add over US$3.2 Million to the region's size and clout in the next 5 to 6 years. Over US$2.6 Million worth of projected demand in the region will come from Rest of Europe markets. In Japan, Transitional Cell Bladder Cancer will reach a market size of US$5.4 Million by the close of the analysis period. As the world's second largest economy and the new game changer in global markets, China exhibits the potential to grow at 7.7% over the next couple of years and add approximately US$26.6 Million in terms of addressable opportunity for the picking by aspiring businesses and their astute leaders. Presented in visually rich graphics are these and many more need-to-know quantitative data important in ensuring quality of strategy decisions, be it entry into new markets or allocation of resources within a portfolio. Several macroeconomic factors and internal market forces will shape growth and development of demand patterns in emerging countries in Asia-Pacific, Latin America and the Middle East. All research viewpoints presented are based on validated engagements from influencers in the market, whose opinions supersede all other research methodologies.

Competitors identified in this market include, among others,, AstraZeneca plc; Bristol-Myers Squibb Company; Celgene Corporation; Eli Lilly and Company; F. Hoffmann-La Roche AG; GlaxoSmithKline PLC; Novartis International AG; Pfizer, Inc.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW

  • Global Competitor Market Shares
  • Bladder Cancer Therapeutics Competitor Market Share Scenario Worldwide (in %): 2019 & 2028

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE

  • TABLE 1: Bladder Cancer Therapeutics Global Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
  • TABLE 2: Bladder Cancer Therapeutics Global Retrospective Market Scenario in US$ Thousand by Region/Country: 2009-2017
  • TABLE 3: Bladder Cancer Therapeutics Market Share Shift across Key Geographies Worldwide: 2009 VS 2019 VS 2025
  • TABLE 4: Transitional Cell Bladder Cancer (Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 5: Transitional Cell Bladder Cancer (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 6: Transitional Cell Bladder Cancer (Type) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 7: Non Muscle Invasive/Superficial Bladder Cancer (Type) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 8: Non Muscle Invasive/Superficial Bladder Cancer (Type) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 9: Non Muscle Invasive/Superficial Bladder Cancer (Type) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 10: Invasive Bladder Cancer (Type) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 11: Invasive Bladder Cancer (Type) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
  • TABLE 12: Invasive Bladder Cancer (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 13: Squamous Cell Bladder Cancer (Type) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 14: Squamous Cell Bladder Cancer (Type) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 15: Squamous Cell Bladder Cancer (Type) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 16: Adenocarcinoma of the Bladder (Type) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 17: Adenocarcinoma of the Bladder (Type) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 18: Adenocarcinoma of the Bladder (Type) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 19: Rare Bladder Cancers (Type) World Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018 to 2025
  • TABLE 20: Rare Bladder Cancers (Type) Market Worldwide Historic Review by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 21: Rare Bladder Cancers (Type) Market Percentage Share Distribution by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 22: Surgery (Treatment) Market Opportunity Analysis Worldwide in US$ Thousand by Region/Country: 2018 to 2025
  • TABLE 23: Surgery (Treatment) Global Historic Demand in US$ Thousand by Region/Country: 2009 to 2017
  • TABLE 24: Surgery (Treatment) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 25: Chemotherapy (Treatment) World Market by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 26: Chemotherapy (Treatment) Historic Market Analysis by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 27: Chemotherapy (Treatment) Market Share Breakdown of Worldwide Sales by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 28: Immunotherapy (Treatment) Potential Growth Markets Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 29: Immunotherapy (Treatment) Historic Market Perspective by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 30: Immunotherapy (Treatment) Market Sales Breakdown by Region/Country in Percentage: 2009 VS 2019 VS 2025
  • TABLE 31: Radiation Therapy (Treatment) Geographic Market Spread Worldwide in US$ Thousand: 2018 to 2025
  • TABLE 32: Radiation Therapy (Treatment) Region Wise Breakdown of Global Historic Demand in US$ Thousand: 2009 to 2017
  • TABLE 33: Radiation Therapy (Treatment) Market Share Distribution in Percentage by Region/Country: 2009 VS 2019 VS 2025
  • TABLE 34: Intravesical Therapy (Treatment) World Market Estimates and Forecasts by Region/Country in US$ Thousand: 2018 to 2025
  • TABLE 35: Intravesical Therapy (Treatment) Market Historic Review by Region/Country in US$ Thousand: 2009 to 2017
  • TABLE 36: Intravesical Therapy (Treatment) Market Share Breakdown by Region/Country: 2009 VS 2019 VS 2025

III. MARKET ANALYSIS

  • GEOGRAPHIC MARKET ANALYSIS
  • UNITED STATES
    • Market Facts & Figures
    • US Bladder Cancer Therapeutics Market Share (in %) by Company: 2019 & 2025
    • TABLE 37: United States Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025
    • TABLE 38: Bladder Cancer Therapeutics Market in the United States by Type: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 39: United States Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 40: United States Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025
    • TABLE 41: Bladder Cancer Therapeutics Market in the United States by Treatment: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 42: United States Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • CANADA
    • TABLE 43: Canadian Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025
    • TABLE 44: Canadian Bladder Cancer Therapeutics Historic Market Review by Type in US$ Thousand: 2009-2017
    • TABLE 45: Bladder Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 46: Canadian Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025
    • TABLE 47: Canadian Bladder Cancer Therapeutics Historic Market Review by Treatment in US$ Thousand: 2009-2017
    • TABLE 48: Bladder Cancer Therapeutics Market in Canada: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
  • JAPAN
    • TABLE 49: Japanese Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025
    • TABLE 50: Bladder Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017
    • TABLE 51: Japanese Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 52: Japanese Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 53: Bladder Cancer Therapeutics Market in Japan: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017
    • TABLE 54: Japanese Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • CHINA
    • TABLE 55: Chinese Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025
    • TABLE 56: Bladder Cancer Therapeutics Historic Market Analysis in China in US$ Thousand by Type: 2009-2017
    • TABLE 57: Chinese Bladder Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 58: Chinese Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 59: Bladder Cancer Therapeutics Historic Market Analysis in China in US$ Thousand by Treatment: 2009-2017
    • TABLE 60: Chinese Bladder Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • EUROPE
    • Market Facts & Figures
    • European Bladder Cancer Therapeutics Market: Competitor Market Share Scenario (in %) for 2019 & 2025
    • TABLE 61: European Bladder Cancer Therapeutics Market Demand Scenario in US$ Thousand by Region/Country: 2018-2025
    • TABLE 62: Bladder Cancer Therapeutics Market in Europe: A Historic Market Perspective in US$ Thousand by Region/Country for the Period 2009-2017
    • TABLE 63: European Bladder Cancer Therapeutics Market Share Shift by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 64: European Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025
    • TABLE 65: Bladder Cancer Therapeutics Market in Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017
    • TABLE 66: European Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 67: European Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
    • TABLE 68: Bladder Cancer Therapeutics Market in Europe in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017
    • TABLE 69: European Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • FRANCE
    • TABLE 70: Bladder Cancer Therapeutics Market in France by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 71: French Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Type: 2009-2017
    • TABLE 72: French Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 73: Bladder Cancer Therapeutics Market in France by Treatment: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 74: French Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Treatment: 2009-2017
    • TABLE 75: French Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • GERMANY
    • TABLE 76: Bladder Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025
    • TABLE 77: German Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017
    • TABLE 78: German Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 79: Bladder Cancer Therapeutics Market in Germany: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 80: German Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
    • TABLE 81: German Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • ITALY
    • TABLE 82: Italian Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025
    • TABLE 83: Bladder Cancer Therapeutics Historic Market Analysis in Italy in US$ Thousand by Type: 2009-2017
    • TABLE 84: Italian Bladder Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 85: Italian Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 86: Bladder Cancer Therapeutics Historic Market Analysis in Italy in US$ Thousand by Treatment: 2009-2017
    • TABLE 87: Italian Bladder Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED KINGDOM
    • TABLE 88: United Kingdom Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025
    • TABLE 89: Bladder Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017
    • TABLE 90: United Kingdom Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 91: United Kingdom Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 92: Bladder Cancer Therapeutics Market in the United Kingdom: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017
    • TABLE 93: United Kingdom Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • SPAIN
    • TABLE 94: Spanish Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025
    • TABLE 95: Spanish Bladder Cancer Therapeutics Historic Market Review by Type in US$ Thousand: 2009-2017
    • TABLE 96: Bladder Cancer Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 97: Spanish Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025
    • TABLE 98: Spanish Bladder Cancer Therapeutics Historic Market Review by Treatment in US$ Thousand: 2009-2017
    • TABLE 99: Bladder Cancer Therapeutics Market in Spain: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
  • RUSSIA
    • TABLE 100: Russian Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025
    • TABLE 101: Bladder Cancer Therapeutics Market in Russia by Type: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 102: Russian Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 103: Russian Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025
    • TABLE 104: Bladder Cancer Therapeutics Market in Russia by Treatment: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 105: Russian Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • REST OF EUROPE
    • TABLE 106: Rest of Europe Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025
    • TABLE 107: Bladder Cancer Therapeutics Market in Rest of Europe in US$ Thousand by Type: A Historic Review for the Period 2009-2017
    • TABLE 108: Rest of Europe Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 109: Rest of Europe Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
    • TABLE 110: Bladder Cancer Therapeutics Market in Rest of Europe in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017
    • TABLE 111: Rest of Europe Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • ASIA-PACIFIC
    • TABLE 112: Asia-Pacific Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
    • TABLE 113: Bladder Cancer Therapeutics Market in Asia-Pacific: Historic Market Analysis in US$ Thousand by Region/Country for the Period 2009-2017
    • TABLE 114: Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Region/Country: 2009 VS 2019 VS 2025
    • TABLE 115: Bladder Cancer Therapeutics Market in Asia-Pacific by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 116: Asia-Pacific Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Type: 2009-2017
    • TABLE 117: Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 118: Bladder Cancer Therapeutics Market in Asia-Pacific by Treatment: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 119: Asia-Pacific Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Treatment: 2009-2017
    • TABLE 120: Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • AUSTRALIA
    • TABLE 121: Bladder Cancer Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025
    • TABLE 122: Australian Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017
    • TABLE 123: Australian Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 124: Bladder Cancer Therapeutics Market in Australia: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 125: Australian Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
    • TABLE 126: Australian Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • INDIA
    • TABLE 127: Indian Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025
    • TABLE 128: Indian Bladder Cancer Therapeutics Historic Market Review by Type in US$ Thousand: 2009-2017
    • TABLE 129: Bladder Cancer Therapeutics Market in India: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 130: Indian Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025
    • TABLE 131: Indian Bladder Cancer Therapeutics Historic Market Review by Treatment in US$ Thousand: 2009-2017
    • TABLE 132: Bladder Cancer Therapeutics Market in India: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
  • SOUTH KOREA
    • TABLE 133: Bladder Cancer Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025
    • TABLE 134: South Korean Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017
    • TABLE 135: Bladder Cancer Therapeutics Market Share Distribution in South Korea by Type: 2009 VS 2019 VS 2025
    • TABLE 136: Bladder Cancer Therapeutics Market in South Korea: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 137: South Korean Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
    • TABLE 138: Bladder Cancer Therapeutics Market Share Distribution in South Korea by Treatment: 2009 VS 2019 VS 2025
  • REST OF ASIA-PACIFIC
    • TABLE 139: Rest of Asia-Pacific Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025
    • TABLE 140: Bladder Cancer Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017
    • TABLE 141: Rest of Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 142: Rest of Asia-Pacific Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 143: Bladder Cancer Therapeutics Market in Rest of Asia-Pacific: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017
    • TABLE 144: Rest of Asia-Pacific Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • LATIN AMERICA
    • TABLE 145: Latin American Bladder Cancer Therapeutics Market Trends by Region/Country in US$ Thousand: 2018-2025
    • TABLE 146: Bladder Cancer Therapeutics Market in Latin America in US$ Thousand by Region/Country: A Historic Perspective for the Period 2009-2017
    • TABLE 147: Latin American Bladder Cancer Therapeutics Market Percentage Breakdown of Sales by Region/Country: 2009, 2019, and 2025
    • TABLE 148: Latin American Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025
    • TABLE 149: Bladder Cancer Therapeutics Historic Market Analysis in Latin America in US$ Thousand by Type: 2009-2017
    • TABLE 150: Latin American Bladder Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 151: Latin American Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 152: Bladder Cancer Therapeutics Historic Market Analysis in Latin America in US$ Thousand by Treatment: 2009-2017
    • TABLE 153: Latin American Bladder Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • ARGENTINA
    • TABLE 154: Argentinean Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025
    • TABLE 155: Bladder Cancer Therapeutics Market in Argentina in US$ Thousand by Type: A Historic Review for the Period 2009-2017
    • TABLE 156: Argentinean Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 157: Argentinean Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
    • TABLE 158: Bladder Cancer Therapeutics Market in Argentina in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017
    • TABLE 159: Argentinean Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • BRAZIL
    • TABLE 160: Bladder Cancer Therapeutics Market in Brazil by Type: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 161: Brazilian Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Type: 2009-2017
    • TABLE 162: Brazilian Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 163: Bladder Cancer Therapeutics Market in Brazil by Treatment: Estimates and Projections in US$ Thousand for the Period 2018-2025
    • TABLE 164: Brazilian Bladder Cancer Therapeutics Historic Market Scenario in US$ Thousand by Treatment: 2009-2017
    • TABLE 165: Brazilian Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • MEXICO
    • TABLE 166: Bladder Cancer Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025
    • TABLE 167: Mexican Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017
    • TABLE 168: Mexican Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 169: Bladder Cancer Therapeutics Market in Mexico: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 170: Mexican Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
    • TABLE 171: Mexican Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • REST OF LATIN AMERICA
    • TABLE 172: Rest of Latin America Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025
    • TABLE 173: Bladder Cancer Therapeutics Market in Rest of Latin America by Type: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 174: Rest of Latin America Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 175: Rest of Latin America Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025
    • TABLE 176: Bladder Cancer Therapeutics Market in Rest of Latin America by Treatment: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 177: Rest of Latin America Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • MIDDLE EAST
    • TABLE 178: The Middle East Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Region/Country: 2018-2025
    • TABLE 179: Bladder Cancer Therapeutics Market in the Middle East by Region/Country in US$ Thousand: 2009-2017
    • TABLE 180: The Middle East Bladder Cancer Therapeutics Market Share Breakdown by Region/Country: 2009, 2019, and 2025
    • TABLE 181: The Middle East Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018 to 2025
    • TABLE 182: The Middle East Bladder Cancer Therapeutics Historic Market by Type in US$ Thousand: 2009-2017
    • TABLE 183: Bladder Cancer Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Type for 2009, 2019, and 2025
    • TABLE 184: The Middle East Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018 to 2025
    • TABLE 185: The Middle East Bladder Cancer Therapeutics Historic Market by Treatment in US$ Thousand: 2009-2017
    • TABLE 186: Bladder Cancer Therapeutics Market in the Middle East: Percentage Share Breakdown of Sales by Treatment for 2009, 2019, and 2025
  • IRAN
    • TABLE 187: Iranian Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Type for the Period 2018-2025
    • TABLE 188: Bladder Cancer Therapeutics Market in Iran: Historic Sales Analysis in US$ Thousand by Type for the Period 2009-2017
    • TABLE 189: Iranian Bladder Cancer Therapeutics Market Share Analysis by Type: 2009 VS 2019 VS 2025
    • TABLE 190: Iranian Market for Bladder Cancer Therapeutics: Annual Sales Estimates and Projections in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 191: Bladder Cancer Therapeutics Market in Iran: Historic Sales Analysis in US$ Thousand by Treatment for the Period 2009-2017
    • TABLE 192: Iranian Bladder Cancer Therapeutics Market Share Analysis by Treatment: 2009 VS 2019 VS 2025
  • ISRAEL
    • TABLE 193: Israeli Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Type: 2018-2025
    • TABLE 194: Bladder Cancer Therapeutics Market in Israel in US$ Thousand by Type: A Historic Review for the Period 2009-2017
    • TABLE 195: Israeli Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 196: Israeli Bladder Cancer Therapeutics Market Estimates and Forecasts in US$ Thousand by Treatment: 2018-2025
    • TABLE 197: Bladder Cancer Therapeutics Market in Israel in US$ Thousand by Treatment: A Historic Review for the Period 2009-2017
    • TABLE 198: Israeli Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • SAUDI ARABIA
    • TABLE 199: Saudi Arabian Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Type for the Period 2018-2025
    • TABLE 200: Bladder Cancer Therapeutics Historic Market Analysis in Saudi Arabia in US$ Thousand by Type: 2009-2017
    • TABLE 201: Saudi Arabian Bladder Cancer Therapeutics Market by Type: Percentage Breakdown of Sales for 2009, 2019, and 2025
    • TABLE 202: Saudi Arabian Bladder Cancer Therapeutics Market Growth Prospects in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 203: Bladder Cancer Therapeutics Historic Market Analysis in Saudi Arabia in US$ Thousand by Treatment: 2009-2017
    • TABLE 204: Saudi Arabian Bladder Cancer Therapeutics Market by Treatment: Percentage Breakdown of Sales for 2009, 2019, and 2025
  • UNITED ARAB EMIRATES
    • TABLE 205: Bladder Cancer Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025
    • TABLE 206: United Arab Emirates Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017
    • TABLE 207: Bladder Cancer Therapeutics Market Share Distribution in United Arab Emirates by Type: 2009 VS 2019 VS 2025
    • TABLE 208: Bladder Cancer Therapeutics Market in the United Arab Emirates: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 209: United Arab Emirates Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
    • TABLE 210: Bladder Cancer Therapeutics Market Share Distribution in United Arab Emirates by Treatment: 2009 VS 2019 VS 2025
  • REST OF MIDDLE EAST
    • TABLE 211: Bladder Cancer Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Type for the Period 2018-2025
    • TABLE 212: Rest of Middle East Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Type: 2009-2017
    • TABLE 213: Rest of Middle East Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 214: Bladder Cancer Therapeutics Market in Rest of Middle East: Recent Past, Current and Future Analysis in US$ Thousand by Treatment for the Period 2018-2025
    • TABLE 215: Rest of Middle East Bladder Cancer Therapeutics Historic Market Analysis in US$ Thousand by Treatment: 2009-2017
    • TABLE 216: Rest of Middle East Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025
  • AFRICA
    • TABLE 217: African Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Type: 2018 to 2025
    • TABLE 218: Bladder Cancer Therapeutics Market in Africa by Type: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 219: African Bladder Cancer Therapeutics Market Share Breakdown by Type: 2009 VS 2019 VS 2025
    • TABLE 220: African Bladder Cancer Therapeutics Market Estimates and Projections in US$ Thousand by Treatment: 2018 to 2025
    • TABLE 221: Bladder Cancer Therapeutics Market in Africa by Treatment: A Historic Review in US$ Thousand for 2009-2017
    • TABLE 222: African Bladder Cancer Therapeutics Market Share Breakdown by Treatment: 2009 VS 2019 VS 2025

IV. COMPETITION

  • ASTRAZENECA PLC
  • BRISTOL-MYERS SQUIBB COMPANY
  • CELGENE CORPORATION
  • ELI LILLY AND COMPANY
  • F. HOFFMANN-LA ROCHE AG
  • GLAXOSMITHKLINE PLC
  • NOVARTIS INTERNATIONAL AG
  • PFIZER

V. CURATED RESEARCH

Back to Top